1. Home
  2. 2-[4-[3-(quinolin-6-ylmethyl)triazolo[4,5-b]pyrazin-5-yl]pyrazol-1-yl]ethanol

Contact Angene

Tel: +852 8191 6999

Email: [email protected]

Brc1cnc(nc1)C
Pyrimidine, 5-bromo-2-methyl-
CCCP1(=O)OP(=O)(CCC)OP(=O)(O1)CCC
1,3,5,2,4,6-Trioxatriphosphorinane, 2,4,6-tripropyl-, 2,4,6-trioxide
CC1(C)OB(OC1(C)C)B1OC(C(O1)(C)C)(C)C
2,2'-Bi-1,3,2-dioxaborolane, 4,4,4',4',5,5,5',5'-octamethyl-
O=C(C=Cc1ccccc1)C=Cc1ccccc1.O=C(C=Cc1ccccc1)C=Cc1ccccc1.O=C(C=Cc1ccccc1)C=Cc1ccccc1.[Pd].[Pd]
Tris(dibenzylideneacetone)dipalladium
C1CCC(CC1)P(C1CCCCC1)C1CCCCC1.Cc1cc(C)c(c(c1)C)N1CCN(C1=[Ru](=Cc1ccccc1)(Cl)Cl)c1c(C)cc(cc1C)C
Ruthenium,[1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene]dichloro(phenylmethylene)(tricyclohexylphosphine)-, (SP-5-41)-

2-[4-[3-(quinolin-6-ylmethyl)triazolo[4,5-b]pyrazin-5-yl]pyrazol-1-yl]ethanol

OCCn1ncc(c1)c1cnc2c(n1)n(nn2)Cc1ccc2c(c1)cccn2 Request for Quotation
Chemical Name: 2-[4-[3-(quinolin-6-ylmethyl)triazolo[4,5-b]pyrazin-5-yl]pyrazol-1-yl]ethanol
CAS Number: 956905-27-4
Product Number: AG01CP5X(AGN-PC-01LTWA)
Synonyms:
MDL No: MFCD12407410
Molecular Formula: C19H16N8O
Molecular Weight: 372.3833

Identification/Properties

Computed Properties
Molecular Weight:
372.392g/mol
XLogP3:
0.7
Hydrogen Bond Donor Count:
1
Hydrogen Bond Acceptor Count:
7
Rotatable Bond Count:
5
Exact Mass:
372.145g/mol
Monoisotopic Mass:
372.145g/mol
Topological Polar Surface Area:
107A^2
Heavy Atom Count:
28
Formal Charge:
0
Complexity:
524
Isotope Atom Count:
0
Defined Atom Stereocenter Count:
0
Undefined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
Covalently-Bonded Unit Count:
1
Compound Is Canonicalized:
Yes

Safety Information

NMR Spectrum

Other Analytical Data

Request for Quotation

Customer Feedback

Chemical Structure


PF-04217903 is a potent and selective inhibitor of the kinases c-Met and Ron. In the realm of chemical synthesis, this compound plays a crucial role in the development of targeted therapies for various types of cancer. By specifically targeting and inhibiting the c-Met and Ron kinases, PF-04217903 can effectively interfere with the signaling pathways involved in promoting cancer cell growth and proliferation. This inhibition ultimately leads to the potential suppression of tumor activity and progression. As a key component in the field of medicinal chemistry, PF-04217903 offers a valuable tool for researchers and pharmaceutical companies alike in their efforts to design and create innovative anticancer drugs with improved efficacy and reduced side effects.